Maze Therapeutics MAZE
NASDAQ MAZE
$27.18 +0.16 (+0.59%)
At close: Sep 30, 2026 · 4:00 PM EDT

Maze Therapeutics (MAZE) Other financing activities (2026)

Updated

Maze Therapeutics (MAZE) reported Other financing activities of $53,000 for Q2 2026, down 94.0% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Other financing activities (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Maze Therapeutics 1.51 Bn 1.51 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53,000.00
Mar 31, 2026 886,000.00
API Access

Maze Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=MAZE&period=max&api_key=YOUR_API_KEY